You are here: Industry Insights > Evotec

News List

Evotec and Celgene Expand IPSC Collaboration to Include Additional Cell Lines firstwordpharma
May 30, 2018
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that the Company will receive a $ 6 m payment from Celgene following Celgene's decision to expand the collaboration to include additional cell lines.
Evotec and Bayer Advance Third Endometriosis Programme into Phase I Clinical Development biospace
April 19, 2018
Evotec AGannounced today that its multi-target alliance with Bayer has advanced another promising small molecule into Phase I
EvoTec to command vast Sanofi resources in infectious disease R&D partnership pharmafile
March 09, 2018
Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation platform in the research and development of new treatments for infectious diseases.
Evotec and Sanofi Collaborate on Infectious Disease R&D Initiative biospace
March 09, 2018
Sanofi Pasteur and Germany-based Evotec AG have teamed up to form an infectious disease research and development program in Lyon, France.
Germany’s Evotec and CRTD to find new therapies for retinal diseases pharmaceutical-technology
December 18, 2017
German drug discovery company Evotec and the Centre for Regenerative Therapies TU Dresden (CRTD) have entered a research collaboration to discover new small molecule candidates for the treatment of retinal diseases.
Evotec and MaRS Innovation launch new drug-discovery partnership pharmaceufical-technology
September 18, 2017
German company Evotec and Canada-based MaRS Innovation (MI) have launched a joint partnership ‘LAB150’ in Toronto, Ontario, Canada.
Evotec buys Aptuit for nearly $300m pharmaceutical-technology
August 18, 2017
German company Evotec has completed the acquisition of Aptuit for a total consideration of approximately $300m to support its long-term strategy to be the industry partner of choice for external drug discovery and development innovation.
Evotec to Pay $300M for Aptuit contractpharma
August 01, 2017
Expands position as leading player in integrated outsourced drug discovery and development solutions
Evotec Opens U.S. HQ in NJ contractpharma
May 27, 2017
Also unveils 20,000 square-foot facility expansion

Previous page 1 2 3 4 Next page